CYP1B1 Mediates Cigarette Smoke-Induced Lipid Accumulation in Alveolar Type 2 Cells

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Cell Biology

Background:

• Altered lipid profiles are observed in chronic obstructive pulmonary disease (COPD) patients.
• The molecular mechanisms driving these lipid alterations, particularly in response to cigarette smoke, are not fully understood.

Purpose of the Study:

• To investigate the role of cytochrome P450 family-1 subfamily B member 1 (CYP1B1) in cigarette smoke-induced lipid accumulation in alveolar type II epithelial (AT2) cells.
• To explore CYP1B1 as a potential therapeutic target for COPD-related lipid dysregulation.

Main Methods:

• Assessed CYP1B1 protein levels in AT2 cells from COPD patients and murine lungs exposed to cigarette smoke (CS).
• Utilized in vitro models with cigarette smoke extract (CSE) and AT2-like cells to examine CYP1B1 expression and lipid accumulation.
• Employed gene silencing (siRNA) and a selective CYP1B1 inhibitor (TMS) to evaluate functional roles.
• Measured mitochondrial reactive oxygen species (ROS) production and apoptosis.

Main Results:

• CYP1B1 protein levels were elevated in AT2 cells from COPD patients and increased upon CS exposure in murine lungs.
• CSE upregulated CYP1B1 expression and induced lipid accumulation in AT2-like cells.
• Overexpression of CYP1B1 promoted lipid accumulation, while its inhibition reduced CSE-induced lipid accumulation.
• Treatment with a CYP1B1 inhibitor (TMS) decreased lipid accumulation, mitochondrial ROS, and apoptosis.

Conclusions:

• Cigarette smoke exposure upregulates CYP1B1 in AT2 cells, contributing to lipid accumulation.
• CYP1B1 plays a critical role in cigarette smoke-induced lipid dysregulation in lung cells.
• Targeting CYP1B1 presents a potential therapeutic strategy for managing lipid abnormalities and lung pathology in COPD.